Patent details

EP2438931 Title: Improved expression of factor IX in gene therapy vectors

Basic Information

Publication number:
EP2438931
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP121503189
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Improved expression of factor IX in gene therapy vectors
French Title of Invention:
Expression améliorée du Facteur IX dans des vecteurs de thérapie génique
German Title of Invention:
Verbesserte Expression von Faktor-IX in Gentherapie-Vektoren
SPC Number:

Dates

Filing date:
09/09/2005
Grant date:
13/11/2013
EP Publication Date:
13/11/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/04/2012
EP B1 Publication Date:
13/11/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/09/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/09/2005
 
 

Name:
St. Jude Children's
Address:
262 Danny Thomas Place, Memphis, Tennessee 38105, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
27/11/2013
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Gray John Trainor
Address:
United States (US)

Priority

Priority Number:
612135 P
Priority Date:
22/09/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 48/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/09/2024
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages